SHMT2 was found to be significantly upregulated at both mRNA and protein levels in the HCC cells (Figure 1B–1C), while the cytosolic isoform SHMT1 is upregulated in Hep3B cells only. Here, SHMT2 is linked to hepatocellular carcinoma.